
zzso and on a molecular level, zzso cancer is a unique and complex zzso The explosion in potential molecular targets over the last decade has led to the arrival of many novel therapies into zzso In the present article, we review the most promising of these agents in zzso zzso 

zzso therapies, such as zzso growth factor zzso zzso that have worked well in other zzso have shown only moderate success in zzso cancer, whereas other treatment approaches have yielded surprisingly positive zzso An example is zzso zzso growth factor and zzso strategies, which are effective in both primary and relapsed zzso zzso Use of zzso zzso zzso has shown that targeting one form of DNA repair profoundly affects cell survival in those with a zzso failure to mend DNA damage using another zzso This can be zzso to patients with sporadic zzso zzso with or without the zzso zzso 

Using targeted agents in zzso cancer, we are discovering not only how these novel therapies work but are also unveiling the complex zzso of the disease itself, and the zzso between what were previously believed to be distinct molecular zzso The addition of targeted agents to our therapeutic zzso is likely to significantly and positively impact on patient zzso 

